Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

142
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
142
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

166
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
166
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

139
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
139
Inflammatory Response01:28

Inflammatory Response

2.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.0K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

664
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
664
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

302
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
302

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Redox Homeostasis in Poultry/Animal Production.

Antioxidants (Basel, Switzerland)·2025
Same author

Changes in Expression of Key Genes in Ceca of Chicken Broilers as Affected by Glyphosate, Antibiotics and a Coccidiostat.

Animals : an open access journal from MDPI·2024
Same author

Nutrigenomics of Natural Antioxidants in Broilers.

Antioxidants (Basel, Switzerland)·2024
Same author

Probiotics as an alternative to antibiotics in modulating the intestinal microbiota and performance of broiler chickens.

Journal of applied microbiology·2023
Same author

Features of Fractal Conformity and Bioconsolidation in the Early Myogenesis Gene Expression and Their Relationship to the Genetic Diversity of Chicken Breeds.

Animals : an open access journal from MDPI·2023
Same author

Identifying mental health training needs of general practice pharmacy workforce to advance practice: a training needs analysis survey.

International journal of clinical pharmacy·2022

Related Experiment Video

Updated: Jul 5, 2025

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
09:11

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model

Published on: February 14, 2021

9.4K

Silymarin and Inflammation: Food for Thoughts.

Peter F Surai1,2,3,4,5,6, Anton Surai7, Katie Earle-Payne8

  • 1Vitagene and Health Research Centre, Bristol BS4 2RS, UK.

Antioxidants (Basel, Switzerland)
|January 22, 2024
PubMed
Summary

Silymarin (SM) and silibinin (SB) show potent anti-inflammatory effects by inhibiting key signaling pathways and reducing pro-inflammatory mediators. These natural antioxidants also promote anti-inflammatory cytokines, aiding in inflammation resolution and health benefits.

Keywords:
antioxidantinflammationoxidative stresssilymarin

More Related Videos

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice
04:47

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice

Published on: October 27, 2023

995
Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
07:50

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

14.3K

Related Experiment Videos

Last Updated: Jul 5, 2025

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
09:11

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model

Published on: February 14, 2021

9.4K
Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice
04:47

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice

Published on: October 27, 2023

995
Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
07:50

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

14.3K

Area of Science:

  • Pharmacology and Toxicology
  • Immunology
  • Natural Product Chemistry

Background:

  • Inflammation is a critical defense mechanism, but its dysregulation can lead to chronic diseases.
  • Oxidative stress and redox imbalance are major drivers of chronic inflammation via pathways like NF-κB.
  • Natural antioxidants are explored for their anti-inflammatory potential.

Purpose of the Study:

  • To investigate the anti-inflammatory properties of silymarin (SM) and its constituent silibinin (SB).
  • To elucidate the molecular mechanisms underlying the anti-inflammatory actions of SM/SB.
  • To evaluate the efficacy of SM/SB in various in vitro and in vivo models of inflammation.

Main Methods:

  • In vitro studies using immune and non-immune cell lines.
  • In vivo studies in various animal models (e.g., NAFLD, ischemia/reperfusion, wound healing).
  • Analysis of signaling pathways (e.g., TLR4/NF-κB) and cytokine expression (pro- and anti-inflammatory).

Main Results:

  • SM/SB significantly inhibited TLR4/NF-κB signaling pathways.
  • SM/SB downregulated pro-inflammatory mediators (e.g., TNF-α, IL-1β, IL-6).
  • SM/SB upregulated anti-inflammatory cytokines (e.g., IL-4, IL-10) and pro-resolution lipid mediators.
  • Anti-inflammatory effects were confirmed across diverse cellular and animal models.

Conclusions:

  • Silymarin and silibinin possess significant anti-inflammatory potential.
  • Their mechanism involves modulating key inflammatory signaling pathways and mediators.
  • These findings highlight SM/SB as promising agents for managing inflammatory conditions and promoting health.